Show simple item record

dc.contributor.authorDewidar, Omar
dc.contributor.authorLotfi, Tamara
dc.contributor.authorLangendam, Miranda W
dc.contributor.authorParmelli, Elena
dc.contributor.authorSaz-Parkinson, ZuleiKa 
dc.contributor.authorSolo, Karla
dc.contributor.authorChu, Derek K
dc.contributor.authorMathew, Joseph L
dc.contributor.authorAkl, Elie A
dc.contributor.authorBrignardello-Petersen, Romina
dc.contributor.authorMustafa, Reem A
dc.contributor.authorMoja, Lorenzo
dc.contributor.authorIorio, Alfonso
dc.contributor.authorChi, Yuan
dc.contributor.authorCanelo-Aybar, Carlos
dc.contributor.authorKredo, Tamara
dc.contributor.authorKarpusheff, Justine
dc.contributor.authorTurgeon, Alexis F
dc.contributor.authorAlonso-Coello, Pablo
dc.contributor.authorWiercioch, Wojtek
dc.contributor.authorGerritsen, Annette
dc.contributor.authorKlugar, Miloslav
dc.contributor.authorRojas, María Ximena
dc.contributor.authorTugwell, Peter
dc.contributor.authorWelch, Vivian Andrea
dc.contributor.authorPottie, Kevin
dc.contributor.authorMunn, Zachary
dc.contributor.authorNieuwlaat, Robby
dc.contributor.authorFord, Nathan
dc.contributor.authorStevens, Adrienne
dc.contributor.authorKhabsa, Joanne
dc.contributor.authorNasir, Zil
dc.contributor.authorLeontiadis, Grigorios
dc.contributor.authorMeerpohl, Joerg
dc.contributor.authorPiggott, Thomas
dc.contributor.authorQaseem, Amir
dc.contributor.authorMatthews, Micayla
dc.contributor.authorSchünemann, Holger J
dc.contributor.authoreCOVID-19 recommendations map collaborators
dc.date.accessioned2023-06-06T10:21:29Z
dc.date.available2023-06-06T10:21:29Z
dc.date.issued2023-06
dc.identifier.citationBMJ Evid Based Med. 2023 Jun;28(3):189-196.es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/16141
dc.description.abstractAn evidence-based approach is considered the gold standard for health decision-making. Sometimes, a guideline panel might judge the certainty that the desirable effects of an intervention clearly outweigh its undesirable effects as high, but the body of supportive evidence is indirect. In such cases, the application of the Grading of Recommendations, Assessment, Development and Evaluations (GRADE) approach for grading the strength of recommendations is inappropriate. Instead, the GRADE Working Group has recommended developing ungraded best or good practice statement (GPS) and developed guidance under which circumsances they would be appropriate.Through an evaluation of COVID-1- related recommendations on the eCOVID Recommendation Map (COVID-19.recmap.org), we found that recommendations qualifying a GPS were widespread. However, guideline developers failed to label them as GPS or transparently report justifications for their development. We identified ways to improve and facilitate the operationalisation and implementation of the GRADE guidance for GPS.Herein, we propose a structured process for the development of GPSs that includes applying a sequential order for the GRADE guidance for developing GPS. This operationalisation considers relevant evidence-to-decision criteria when assessing the net consequences of implementing the statement, and reporting information supporting judgments for each criterion. We also propose a standardised table to facilitate the identification of GPS and reporting of their development. This operationalised guidance, if endorsed by guideline developers, may palliate some of the shortcomings identified. Our proposal may also inform future updates of the GRADE guidance for GPS.es_ES
dc.description.sponsorshipCIHR (FRN VR4-172741 & GA3-177732) for COVID-19 recommendation mapping. AFT is the Chairholder of the Canada Research Chair in Critical Care Neurology and Trauma.es_ES
dc.language.isoenges_ES
dc.publisherBMJ Publishing Group es_ES
dc.type.hasVersionVoRes_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/*
dc.subjectCOVID-19es_ES
dc.subjectEvidence-Based Practicees_ES
dc.subject.meshEvidence-Based Medicine es_ES
dc.subject.meshCOVID-19es_ES
dc.subject.meshHumans es_ES
dc.subject.meshResearch Design es_ES
dc.titleGood or best practice statements: proposal for the operationalisation and implementation of GRADE guidancees_ES
dc.typejournal articlees_ES
dc.rights.licenseAtribución-NoComercial 4.0 Internacional*
dc.identifier.pubmedID35428694es_ES
dc.format.volume28es_ES
dc.format.number3es_ES
dc.format.page189-196es_ES
dc.identifier.doi10.1136/bmjebm-2022-111962es_ES
dc.contributor.funderCanada Research Chairs es_ES
dc.contributor.funderCanadian Institutes of Health Research es_ES
dc.description.peerreviewedes_ES
dc.identifier.e-issn2515-4478es_ES
dc.relation.publisherversionhttps://doi.org/10.1136/bmjebm-2022-111962es_ES
dc.identifier.journalBMJ evidence-based medicinees_ES
dc.repisalud.centroISCIII::Agencia de Evaluación de Tecnologías Sanitariases_ES
dc.repisalud.institucionISCIIIes_ES
dc.rights.accessRightsopen accesses_ES


Files in this item

Acceso Abierto
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Atribución-NoComercial 4.0 Internacional
This item is licensed under a: Atribución-NoComercial 4.0 Internacional